Most Popular White Papers
Content provided in partnership with
Manufacturing Industry
Vioxx saga
Chemistry and Industry, Sept 24, 2007
Pharmaceutical giant Merck & Co was able to celebrate a legal victory in the US after New Jersey's Supreme Court made a ruling that could save it from class-action lawsuits related to its troubled painkiller Vioxx. Vioxx was withdrawn from the market due to an increased risk of heart attack and stroke (C&I 2006,17, 6).
The Supreme Court reversed the decision of two lower courts deciding that lawsuits against Merck have to be brought by individuals or companies. Merck had estimated that a class-action lawsuit could have cost it up to $18bn (13bn [euro]).
COPYRIGHT 2007 Society of Chemical Industry
COPYRIGHT 2008 Gale, Cengage Learning
Find Research Guides for:
Find Featured Titles for: Technology
Most Popular Articles in Technology
- An overview of continuous data protection
- Why all those current ratings?
- Many countries now have a mobile penetration rate above 100%, report says
- The Tata Group's big telecom gamble: VSNL's recent acquisition of Tyco ...
- MEASURING BANK BRANCH EFFICIENCY USING DATA ENVELOPMENT ANALYSIS: MANAGERIAL ...
- More »